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AntisenseHuman T-cell leukemia virus type 1 (HTLV-1) basic leucine zipper factor (HBZ) is transcribed from the
antisense genomic DNA strand and functions differently in its RNA and protein forms. To distinguish between
the roles of hbzmRNA and HBZ protein, we generated mutants in a proviral clone that speciﬁcally disrupt the
hbz gene product. A proviral clone with a splice acceptor mutation that disrupts expression of the
predominant hbz mRNA resulted in lower levels of tax mRNA. Heterologous hbz expression restored Tax
activity in cells expressing this mutant clone. In contrast, proviral mutants that disrupt HBZ protein did not
affect levels of taxmRNA. Expression of hbz resulted in lower levels of p30IImRNA. Mutation of p30II overcame
the effects of the splice acceptor mutation of hbz, and restored tax expression. Thus, there is a complex
interplay of viral regulatory proteins controlling levels of HTLV-1 gene expression.t. Louis, MO 63110. Fax: +1 314
l rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
Human T-cell leukemia virus type 1 (HTLV-1) is a complex
retrovirus belonging to the delta retrovirus family. It is the etiologic
agent of adult T cell leukemia lymphoma (ATLL) (Hinuma et al., 1981;
Poiesz et al., 1980), a malignancy of CD4+ T lymphocytes, and a
chronic neurological disorder termed HTLV-1-associatedmyelopathy/
tropical spastic paraparesis (HAM/TSP). In addition to the gag, env,
and pol genes encoding structural and enzymatic proteins common to
all retroviruses, the HTLV-1 genome includes several accessory
proteins, which facilitate virus transmission in vivo by establishing
persistent infection (Collins et al., 1998; Hiraragi et al., 2006; Nicot
et al., 2004; Silverman et al., 2004; Ye et al., 2003). The tax gene
product is a potent activator of viral transcription (Boxus and
Willems, 2009; Felber et al., 1985; Yin and Gaynor, 1996). In addition,
through its involvement in a number of cellular transcription
pathways, Tax stimulates the proliferation, survival, and transforma-
tion of HTLV-1-infected T cells (Boxus and Willems, 2009; Matsuoka
and Jeang, 2007; Peloponese et al., 2007). Another regulatory protein,
p30II, down-regulates Tax expression by interaction with, and nuclear
retention of tax mRNA (Nicot et al., 2004). Other HTLV-1 regulatory
proteins include Rex, p12I, p27I, and p13II (Fig. 1) (Albrecht and
Lairmore, 2002).
Recently, another HTLV-1 regulatory gene was identiﬁed on the
antisense genomic DNA strand; since its protein product includes abasic region and a leucine zipper, it was designated HTLV-1 bZIP
factor, or HBZ (Cavanagh et al., 2006; Gaudray et al., 2002; Larocca
et al., 1989). The hbzmRNA is expressed in primary ATLL cells, despite
repression of other viral transcripts (Matsuoka and Green, 2009;
Satou et al., 2006). Multiple hbz mRNA initiation sites have been
identiﬁed in the 3′-LTR (Cavanagh et al., 2006; Yoshida et al., 2008),
which result in three transcripts; two are spliced (hbz SP1 and SP2)
while the other is unspliced (hbz US) (Fig. 1) (Cavanagh et al., 2006;
Murata et al., 2006; Satou et al., 2006). The SP1 spliced variant is the
most abundant form in ATLL cell lines and infected lymphocytes from
ATLL patients (Satou et al., 2006; Usui et al., 2008). The promoters for
hbz SP1 and hbz US have been identiﬁed, and studies suggest that the
levels of antisense transcription are 20- to 50-fold lower (Arnold et al.,
2006; Larocca et al., 1989) than sense transcription (Yoshida et al.,
2008). The hbz SP1 and hbz US mRNAs encode protein products that
differ only in their N-terminal seven amino acids, whereas the SP2
transcript does not code for a protein product, and its function is
undeﬁned. The hbz transcripts include sequences complementary to
the other HTLV-1 transcripts encoded from the sense genomic DNA
strand.
HBZ has been reported to be a negative modulator of Tax. Upon
exogenous over-expression, HBZ binds to and inhibits CREB-2, an
essential transcription factor for Tax-mediated trans-activation of the
viral promoter (Basbous et al., 2003; Gaudray et al., 2002). However,
HBZ expression does not affect the ability of HTLV-1 to immortalize T
lymphocytes in culture (Arnold et al., 2006); in fact, HBZ enhances
virus infectivity and persistence in vivo. Another study identiﬁed a
distinct activity of hbz mRNA, and demonstrated enhanced T cell
proliferation in culture and transgenic mice (Satou et al., 2006). They
Fig. 1. Schematic representation of the HTLV-1 genome. The viral mRNAs, their direction of transcription and location of the open reading frames (black boxes) are shown. hbz SP1
and SP2 are two spliced variants of hbzmRNA,while hbz US is the unspliced transcript. The dotted lines represent the introns removed after mRNA splicing. The arrows represent the
primers used to amplify the viral mRNAs for the RT-PCR assays. The white cross in p30 represents the location of the p30 stop codon, introduced to generate the Δp30 mutants. The
black line above hbz SP1 represents the location of the stem–loop structure in hbz.
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that mediated this activity. These data led to the hypothesis that the
hbz gene has dual functionality: hbz mRNA promotes T-cell prolifer-
ation, while HBZ protein suppresses Tax-mediated viral transcription.
In order to delineate and differentiate the activities of hbz mRNA
and HBZ protein, we used an infectious molecular proviral clone of
HTLV-1 (Kimata et al., 1994) to assess mutations that speciﬁcally
affect the structure and/or expression of the hbz gene product. This led
to the unexpected identiﬁcation of a third activity of hbz that
promotes tax mRNA expression. These results have important
implications for understanding the regulation of HTLV-1 gene
expression.
Results
Construction and characterization of pACH.HBZ mutant proviral clones
To investigate the role of HBZ in the context of an HTLV-1 provirus,
we generated four HBZ mutant proviral clones (Fig. 2A). For this
purpose, we used a well characterized infectious molecular clone,
designated pACH (Kimata et al., 1994). pACH.HBZ-ΔSA has a mutation
in the splice acceptor site of the hbz gene that prevents the proper
splicing of the SP1 and SP2 hbz mRNAs (Fig. 1). pACH.HBZ-KO is a
knockout mutant that terminates the predominant HBZ protein
derived from the SP1 variant at amino acid seven, as well as the
HBZ protein derived from the US variant at amino acid 10 (Fig. 2A).
pACH.HBZ-TRUN is a truncation mutant that deletes the leucine
zipper portion of the bZIP domain of variants SP1 and US, through
insertion of a termination codon in place of codon 158 (SP1)/codon
161 (US) within the 206 (SP1)/209 (US) amino acid open reading
frame. The leucine zipper portion of HBZ is required for the
association of HBZ with CREB-2, JunB, and c-Jun (Basbous et al.,
2003; Gaudray et al., 2002). pACH.HBZ-SL has amutation that disrupts
the stem–loop at the 5′ end of the hbzmRNA that is only found in the
SP1 variant (Satou et al., 2006). Although mutants similar to pACH.
HBZ-KO and pACH.HBZ-TRUN were constructed and tested by other
investigators (Arnold et al., 2006), our studies were aimed at
distinguishing the role of hbz mRNA versus HBZ protein at
physiological levels.
We ﬁrst determined the levels of hbz SP1 RNA expressed from the
proviral mutant plasmids (Fig. 2B). 293T cells were transientlytransfected with each of the various mutants, and total RNA isolated
from these cells was subjected to real-time RT-PCR, using primers that
spanned the hbz splice junction (Fig. 1). The results from an average of
at least three independent experiments are shown in Fig. 2B. Mutating
the splice acceptor site of the hbz gene signiﬁcantly reduced the
steady state levels of hbz SP1 RNA by greater than 90% (P=0.03). As
expected, mutants pACH.HBZ-KO and pACH.HBZ-TRUN, which were
constructed to truncate the HBZ protein without affecting hbzmRNA,
were found to have no signiﬁcant effects on the levels of hbz RNA
(pACH.HBZ-KO: P=0.57; pACH.HBZ-TRUN: P=0.15). Disrupting the
stem–loop structure of hbzmRNA did not affect the stability of the hbz
mRNA, since steady state levels were equivalent to those of cells
expressing pACH.HBZ-WT (P = 0.35). We also measured levels of
total hbz RNA in cells transfected with the pACH.HBZ-WT and pACH.
HBZ-ΔSA plasmids (Fig. 2B, inset), and found that the levels were
decreased by 69% in the presence of the splice acceptor mutation.
These levels of total hbz most likely correspond to the hbz US
transcript, as this level is consistent with previously reported levels of
hbz US (Usui et al., 2008).
In order to examine the expression of HBZ protein from the various
mutants, we generated HBZ wild-type (pHBZ) and mutant (pHBZ-KO,
pHBZ-TRUN, and pHBZ-SL) expression plasmids, inserting a triple ﬂag
tag at the C-terminus of each predicted protein product. 293T cells
were transiently transfected with these plasmids, and Western blot
analysis was carried out (Fig. 2C). As expected, no HBZ expressionwas
seen from cells transfected with the HBZ-KO mutant. The HBZ-TRUN
mutant produced a truncated HBZ-ﬂag protein of 27 kDa. Cells
expressing wild-type HBZ and the HBZ-SL mutant both produced
HBZ-ﬂag proteins of 34 kDa. Levels of expression of WT, TRUN, and SL
HBZ proteins were equivalent.
To conﬁrm that pACH.HBZ-ΔSA does not produce an unspliced
gene product, we generated an HBZ-ΔSA expression plasmid (pNHBZ-
ΔSA) that contains both the exons of hbz SP1 and the sequence
corresponding to the intronic region between them. 293T cells were
transiently transfected with this plasmid and a HBZ wild-type
expression plasmid, pNHBZ, and Western blot analysis was carried
out with anti-HBZ antiserum (Fig. 2D). We did not see any HBZ
expression frompNHBZ-ΔSA, conﬁrming the lack of an unspliced gene
product. Additionally, we did not see a difference in unspliced mRNA
levels between cells transfected with the wild-type and ΔSA mutant
proviral plasmids (data not shown).
Fig. 2. Analysis of the hbzmRNA transcript and HBZ protein. (A) Schematic representation of wild-type HBZ (WT), with its splice donor (SD) and acceptor (SA) sites and bZIP domain
indicated. The four HBZ mutants generated for this study are also depicted. These mutants were made in the context of the pACH proviral clone. ΔSA, splice-deﬁcient mutant; KO,
knockout mutant; TRUN, truncation mutant; SL, stem–loop mutant. (B) 293T cells were transfected with the pACH.HBZ-WT or mutant plasmids. Total RNA was isolated 96 h post-
transfection, and the hbz SP1 mRNA ampliﬁed by real-time RT-PCR using primers shown in Fig. 1. Background values were subtracted and data normalized to WT. GAPDH was
ampliﬁed as an internal control, and did not differ signiﬁcantly between samples. These results represent an average of at least three independent experiments. Inset, total hbzmRNA
was ampliﬁed by real-time RT-PCR using the primers within exon 2 of the hbz gene shown in Fig. 1. Background values were subtracted and data normalized to WT (ΔSA value is
0.31). Student's two-tailed t tests were performed to determine signiﬁcant differences between samples (*Pb0.05; **P b 0.01). (C) 293T cells were transfected with pHBZ1 (pHBZ) or
mutant HBZ expression plasmids. Western blot analysis was carried out to show HBZ-ﬂag expression from these plasmids, using anti-Flag antibody. The size of the proteins is
indicated to the right of the blot. Detection of actin was carried out as a loading control. (D) 293T cells were transfected with pNHBZ or pNHBZ-ΔSA expression plasmids. Western
blot analysis was carried out to show HBZ expression (arrow) from these plasmids, using anti-HBZ antibody. Detection of actin was carried out as a loading control. The background
bands (bkgd. bands) are indicated to the left of the blot. **, the intensity of this band (as compared to the others) is probably due to protein degradation. It cannot represent an HBZ
protein translated using an internal ATG, since there is no start site that would produce a protein of that size.
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The pACH.HBZ mutants were used to determine the effects of hbz
mRNA and HBZ protein on expression of other HTLV-1 genes. Total
RNA isolated from 293T cells transiently transfected with the HBZ
proviral mutants was subjected to real-time RT-PCR to measure the
levels of tax transcript. The primers used to amplify tax spanned the
second splice junction (Fig. 1). The results from an average of four
independent experiments are shown in Fig. 3A. There was a 70%
decrease in the steady state level of tax mRNA expressed from the
pACH.HBZ-ΔSA mutant, as compared to the level of tax mRNA
expressed by pACH.HBZ transfected cells. Jurkat cells transfected
with the pACH.HBZ-WT plasmid expressed 0.12 ± 0.07 pg taxmRNA,
while those transfected with the pACH.HBZ-ΔSA mutant plasmid
expressed 0.0 ± 0.02 pg tax mRNA (P=0.03) (data not shown). No
signiﬁcant changes were seen in tax mRNA expressed from the other
pACH mutants (Fig. 3A). The levels of tax mRNA, relative to that of
pACH.HBZ-WT expressing cells, with pACH.HBZ-KO, pACH.HBZ-
TRUN, and pACH.HBZ-SL were 87%, 104%, and 73%, respectively
(P = 0.78, 0.96, and 0.51, respectively).
Levels of viral proteins were also assessed, and normalized to
levels of actin, used as a loading control (Fig. 3B). There was a 64%
decrease in the amount of Tax protein expressed from the pACH.HBZ-ΔSA mutant, compared to Tax protein expressed from pACH.HBZ
transfected cells. No signiﬁcant decrease in Tax protein was seen with
the other mutants.
Since Tax is responsible for the trans-activation of viral transcrip-
tion, the levels of the viral structural protein, Gag were measured in
the cellular lysate and virus particles in the culture supernatant. As
expected, levels of Gag p24 and p19 were also decreased in cells
transfected with pACH.HBZ-ΔSA compared to pACH.HBZ-WT (Fig. 3B,
lane 3), as well as in virus particles released into the supernatant from
those cells (Fig. 3C, lane 3). These results suggest that the effect of hbz
mRNA on the levels of tax mRNA also inﬂuences the levels of Gag
expression in transfected cells and the levels of released virus
particles.
Trans-complementation of hbz increases Tax activity in pACH.HBZ-ΔSA
cells to wild-type levels
To ensure that the effects on steady state levels of Tax in pACH.
HBZ-ΔSA transfected cells were due to loss of hbz mRNA, we
measured levels of Tax-mediated LTR gene expression in the presence
of increasing amounts of hbz. Co-transfection of pACH.HBZ-WT or
pACH.HBZ-ΔSA, as a source of Tax, together with an LTR-luciferase
reporter plasmid, provided a sensitive quantitative measure of Tax
Fig. 3. HTLV-1 gene expression in the absence of hbzmRNA or HBZ protein. (A) 293T cells
were transfectedwith the pACH.HBZ-WT ormutant plasmids. Total RNAwas isolated 96 h
post-transfection, and the taxmRNA ampliﬁed by real-time RT-PCR, using primers shown
in Fig. 1. GAPDH was ampliﬁed as an internal control, and did not exhibit signiﬁcant
differences between samples. These results represent an average of four independent
experiments. Student's two-tailed t tests were performed to determine signiﬁcant
differences between samples (*Pb0.05). (B and C) Western blot analysis was carried out
to measure levels of Tax and Gag (p19 and p24) proteins in the (B) lysates and (C) viral
supernatant.Detectionof actinwas carriedout as a loading control. Thenumbers above the
blots represent the lane numbers, while the numbers below the blots represent the
densitometry signal of the bands. A representative experiment is shown from a total of
three experiments. Student's two-tailed t tests were performed to determine signiﬁcant
differences between samples (B; *P b 0.05; **P b 0.01). Signiﬁcant differences were seen
between the WT and ΔSA samples (Tax: P=0.0002, p24: P = 0.046, p19: P = 0.048),
whereas no differences were seen between theWT and KO (Tax: P=0.76, p24: P=0.81,
p19: P=0.82),WT and TRUN (Tax: P=0.58, p24: P=0.53, p19: P=0.38), orWT and SL
(Tax: P= 0.08, p24: P= 0.11, p19: P= 0.79) samples.
Fig. 4. Trans-complementation with heterologous hbz rescues the defect seen with the
mutation of hbz in the pACH infectious clone. (A) 293T cells were co-transfected with
LTR-luc, and with the pACH.HBZ-WT or pACH.HBZ-ΔSA plasmids, or CMV-Tax, in the
presence of increasing amounts of pHBZ. Luciferase assays were carried out 48 h post-
transfection. Student's two-tailed t tests were performed to determine signiﬁcant
differences between samples (*Pb0.05; **P b 0.01). A representative experiment is
shown from three total experiments. (B and C) 293T cells were transfected with the
pACH.HBZ-WT or pACH.HBZ-ΔSA plasmids in the presence or absence of pHBZ. At 96 h
post-transfection Western blot analysis was carried out to measure levels of Gag (p19
and p24) proteins in the (B) lysates and (C) viral supernatant. Detection of actin was
carried out as a loading control. The numbers above the blots represent the lane
numbers, while the numbers below the blots represent the densitometry signal of the
bands. Student's two-tailed t tests were performed to determine signiﬁcant differences
between samples (*P b 0.05).
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pACH plasmid is able to trans-activate the HTLV-1 LTR (Robek and
Ratner, 1999). In that study, the speciﬁc role of Tax in transcriptional
transactivation was conﬁrmed using theM47 Taxmutation in pACH, a
mutation which prevents Tax from upregulating transcription
through CREB/ATF (Smith and Greene, 1990). This mutant had 50-fold lower levels of HTLV-1 LTR activation, using the LTR-luciferase
reporter plasmid, compared to wild-type pACH.
In the trans-complementation experiment with hbz, increasing
quantities of a plasmid were utilized in which hbz was expressed
under the regulation of a CMV promoter, pHBZ (Fig. 4A). In cells
transfected with pACH.HBZ-ΔSA, together with increasing amounts of
the hbz expression plasmid, the levels of LTR-directed gene expression
increased. It should be noted that in the presence of 4 μg pHBZ, the
level of Tax activity in pACH.HBZ-ΔSA transfected cells increased to
levels seen in pACH.HBZ-WT transfected cells. The levels of Tax
311G. Choudhary, L. Ratner / Virology 410 (2011) 307–315activity also increased in cells transfected with pACH.HBZ-WT in the
presence of pHBZ. However, there was no signiﬁcant increase in Tax
activity with increasing amounts of pHBZ in cells transfected with a
Tax expression plasmid (CMV-Tax). One explanation for this result is
that another viral gene, expressed from the proviral plasmid, is
required for the effect of hbz on tax expression.
As in the previous experiment (Fig. 3), we examined the levels of
Gag protein in the cellular lysate and viral supernatant, as a further
measure of Tax activity. As expected, the levels of Gag p24 in the
lysate increased in the presence of exogenous hbz (Fig. 4B, lanes 4 and
6, compared to lanes 3 and 5, respectively), and signiﬁcantly more
viral particles were released into the supernatant (Fig. 4C, lanes 4 and
6, compared to lanes 3 and 5, respectively).
hbz represses p30II to indirectly promote tax expression
The HTLV-1 accessory protein p30II is a nuclear protein that retains
the doubly spliced taxmRNA in the nucleus, leading to a reduction in
the amount of Tax protein (Nicot et al., 2004). Since p30II is a negative
regulator of tax, we hypothesized that hbz may negatively regulate
p30II in order to promote tax mRNA expression. Since hbz mRNA is
transcribed from the (−) strand of the HTLV-1 provirus, it is a natural
antisense RNA to genes expressed from the (+) proviral DNA strand.Fig. 5. Expression of hbz depresses p30II levels, and loss of p30II compensates for loss of hbz. (A
pHBZ2 (HBZ) or pmHBZ (mHBZ). Total RNA was isolated 48 h post-transfection, and the p30
did not exhibit signiﬁcant differences between samples. A representative experiment is sh
signiﬁcant differences between samples (** Pb0.01). (B) 293T cells were transfected with pM
was carried out 48 h post-transfection to measure levels of HBZ and p30 protein. Detection o
densitometry signal of the bands, normalized to levels of actin. (C and D) 293T cells were tra
mutation, WTΔp30 and ΔSAΔp30. At 48 h post-transfection, Western blot analysis was carrie
indicates background bands. Detection of actin was carried out as a loading control. The nu
represent the densitometry signal of the bands.Since the majority of the hbz transcript overlaps the p30II transcript,
we hypothesized that the hbz mRNA binds to the p30II mRNA to
promote its degradation or inhibit its translation.
To test our hypothesis, we co-transfected 293T cells with
pMHp30IIHA1, a p30II expression plasmid and pHBZ, and carried out
real-time RT-PCR on total RNA from the cells (Fig. 5A). In the presence
of increasing amounts of HBZ, we saw a signiﬁcant decrease in the
levels of p30IImRNA. To determine whether this effect was dependent
on HBZ protein or hbzmRNA, we generated a protein mutant of pHBZ,
pmHBZ, mutating the initiator ATG to TTG. In the presence of
increasing amounts of mutant pHBZ, we also found a signiﬁcant
decrease in the levels of p30II mRNA, suggesting that the hbz mRNA,
not the HBZ protein, is responsible for the decreased levels of p30II
mRNA. The p30II protein levels were also reduced in the presence of
wild-type HBZ and the protein mutant of HBZ, mHBZ, whereas the
p30II protein levels remained unchanged in the presence of the RNA
mutant of HBZ, pNHBZ-ΔSA (Fig. 5B), conﬁrming that hbz mRNA
inhibits synthesis of p30II protein.
To investigate the role of p30II, we generated two p30II mutant
proviral clones. Both pACHΔp30 and pACH.HBZ-ΔSAΔp30 include a
termination codon in place of amino acid eight of the p30II open
reading frame, in the context of the hbz wild-type and hbz splice-
deﬁcient expression plasmids, respectively (Fig. 1). 293T cells were) 293T cells were transfected with pMHp30IIHA1 (p30) and increasing amounts of either
mRNA ampliﬁed by real-time RT-PCR. GAPDH was ampliﬁed as an internal control, and
own from two experiments. Student's two-tailed t tests were performed to determine
Hp30IIHA1 (p30) and either HBZ, mHBZ, pNHBZ, or pNHBZ-ΔSA. Western blot analysis
f actin was carried out as a loading control. The numbers below the blots represent the
nsfected with the pACH.HBZ-WT or pACH.HBZ-ΔSA plasmids with or without the p30II
d out on the (C) lysates and (D) viral supernatant for levels of viral Gag (p19 and p24). *,
mbers above the blots represent the lane numbers, while the numbers below the blots
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supernatant evaluated for levels of Gag (p24 and p19) protein. In the
absence of p30II, there was a 1.95-fold increase in the levels of Gag
protein in the cellular lysate (Fig. 5C, lane 3, compared to lane 2) and a
four-fold increase over wild-type in the viral supernatant (Fig. 5D,
lane 3, compared to lane 2), which corresponds, as expected, to an
increase in the level of Tax protein. As seen previously (Fig. 3), loss of
hbz leads to a decrease in the amount of Gag protein in the cellular
lysate and supernatant (Figs. 5C and D, lane 4). However, the loss of
hbzwas overcome by deleting p30II, as evidenced by an increase in the
levels of Gag protein in the cellular lysate (Fig. 5C, lane 5) and viral
supernatant (Fig. 5D, lane 5) from cells transfected with pACH.HBZ-
ΔSAΔp30. Taken together, these results suggest that hbz promotes
expression of tax indirectly through p30II.
Discussion
Since the discovery of the HTLV-1 antisense hbz gene (Gaudray
et al., 2002), numerous studies have been carried out to establish its
role in HTLV-1 replication and pathogenesis. Though these studies have
been informative and have established a foundation for hbz in the
HTLV-1 ﬁeld, the function of hbz in vivo is still unclear. HBZ was
identiﬁed as a binding partner to CREB-2; it binds CREB-2 through its
basic leucine zipper (bZIP) domain (Gaudray et al., 2002). Since CREB-2
has been shown to cooperate with Tax in trans-activating the HTLV-1
LTR (Ching et al., 2004), studies have shown that exogenously over-
expressed HBZ protein down-regulated Tax-mediated viral transcrip-
tion by binding CREB-2 (Gaudray et al., 2002; Lemasson et al., 2007).
Furthermore, Tax has been shown to activate a number of cellular
pathways, such as the activator protein-1 (AP-1) pathway (Fujii et al.,
1991, 1988; Hooper et al., 1991). Studies with exogenous HBZ showed
that, through its bZIP domain, HBZ could bind to members of the AP-1
pathway (cJun and JunB) and down-regulate Tax-mediated AP-1
transcription (Basbous et al., 2003; Clerc et al., 2009; Hivin et al.,
2007; Matsumoto et al., 2005). However, since these studies employed
over-expression of HBZ in the absence of other viral proteins, a more
physiologically relevant study was carried out using HBZ expressed
from a molecular clone of HTLV-I (Arnold et al., 2006). Data from this
study showed that HBZ protein enhanced viral infectivity and
persistence in vivo. In addition to this function of HBZ protein, the hbz
mRNA has been shown to promote T-cell proliferation (Arnold et al.,
2008; Satou et al., 2006).
Since previous studies suggested that hbz has dual functionality,
we examined the effects of various proviral hbz mRNA and protein
mutants on viral gene expression. We showed that a loss of hbzmRNA
leads to a signiﬁcant reduction in the levels of taxmRNA (Fig. 3). This
reduction of taxmRNA leads, as expected, to lower Tax protein levels,
and a reduction in the levels of Gag protein and virus particle
production. These data are in contrast to previous work that showed
that hbz-speciﬁc short hairpin (sh)-RNAs, which down-regulated the
levels of hbz in an HTLV-1 T-cell line, did not affect levels of gag/pol
and tax/rexmRNAs or p19 Gag and Tax protein (Arnold et al., 2008). A
possible reason for this discrepancy is discussed below.
To conﬁrm that the reduction in Tax levels was a consequence of
the loss of hbz mRNA, a complementation study was carried out in
which increasing amounts of exogenous hbz were expressed. In
contrast to previous work (Arnold et al., 2006), we found that when
Tax was expressed from a proviral plasmid, the levels of Tax activity
increased with increasing amounts of pHBZ (Fig. 4). Of particular note
is that, in the presence of 4ug of pHBZ, Tax activity in cells transfected
with the splice-deﬁcient hbz mutant increased to wild-type levels.
Another interesting ﬁnding was that when Tax was expressed
from an expression plasmid rather than a proviral expression plasmid,
there was no increase in Tax activity in the presence of pHBZ (Fig. 4).
We concluded that a viral gene, expressed from the proviral plasmid,
was required for hbz to have its effect on tax. Alternatively, there is thepossibility that there are differences in the cis-sequences of the RNA
expressing Tax encoded by the proviral plasmid compared to that
encoded by the Tax expression plasmid. However, this would imply
that hbz has a direct effect on tax, but we do not favor this possibility,
as discussed below. Possible explanations for the result seen in Fig. 4
are: (1) hbz represses an inhibitor of tax, (2) hbz promotes an activator
of tax, or (3) hbz has a direct effect on tax. The ﬁrst hypothesis is more
attractive for the following reasons. First, since hbz is transcribed from
the (−) strand of the HTLV-1 proviral genome, it is a natural antisense
RNA to other viral transcripts; it could form a double stranded (ds)-
RNA structure with other viral transcripts, which may be degraded by
cellular nucleases or merely inhibit their translation. Second, it is
notable that the HTLV-1 gene encoding p30II has a repressive function
on tax (Nicot et al., 2004), similar to that manifested by loss of hbz. The
p30II protein retains doubly spliced taxmRNA in the nucleus, thereby
decreasing the levels of Tax protein. It is notable that the hbz
transcript overlaps those encoding pX open reading frames I and II,
which encode p12I and p30II and p13II, respectively (Fig. 1). Of the
three accessory proteins encoded by these regions of the viral
genome, only p30II has been shown to directly regulate tax expression
(Albrecht and Lairmore, 2002). Hence, we hypothesized that hbz
inhibits p30II mRNA, and the reduction in p30II protein expression
leads to an increase in the levels of Tax protein. Moreover, steady state
levels of p30II mRNA are low compared to the level of hbz mRNA, in
contrast to levels of tax and gag mRNAs, thus p30II mRNA would be
predicted to be exquisitely sensitive to inhibition by a complementary
RNA sequence.
The discrepancy between the currently reported studies and those
reported previously based on studies of the effects of shRNAs to hbz
(Arnold et al., 2008) can be explained by the fact that the expression
of p30II may have been suppressed in the transformed cell lines used
in the previous study. Furthermore, it is unclear whether the shRNAs
were able to reduce the levels of hbz RNA effectively enough to repress
its effect on p30II. Another difference between the current study with
an infectious proviral clone and the previous study using transformed
cell lines may be related to differences in levels of hbz mRNA and its
mechanism of gene expression. It is unclear whether hbz expression in
transformed cell lines is derived predominantly from intact proviruses
or deleted proviruses (Matsuoka and Green, 2009). Expression of hbz
mRNA from a deleted provirus in ATLL cell lines may repress tax
expression from intact proviruses in the same cell, which may
resemble the results in the current study in which trans-complemen-
tation effects of hbz were examined (Fig. 4). Although (+) strand
transcriptional occlusion of the hbz promoters in an intact provirus
may inhibit its expression, we found only four-fold lower levels of hbz
mRNA generated from the full provirus compared to that generated
from the 3′ half of the provirus, under our transient transfection
conditions (data not shown). Thus, promoter occlusion is not likely a
major restrictive mechanism for hbz expression except when the 5′
LTR promoter is highly upregulated (Greger et al., 1998; Palmer et al.,
2009).
To examine the effect of hbz on p30II, we measured levels of p30II
mRNA in the presence of increasing amounts of wild-type HBZ and an
HBZ protein mutant. We found that levels of p30II mRNA were
signiﬁcantly reduced in either case, implicating hbz mRNA for this
function (Fig. 5). Furthermore, we generated two p30II mutants in the
context of the hbzwild-type and hbz splice-deﬁcient mutant plasmids,
to examine the effect of p30II on Tax activity. We observed that in the
absence of p30II, there was an increase in the levels of Gag proteins,
and virus particle production (Fig. 5). Further studies focusing on the
relationship between hbz and p30II mRNA will further deﬁne the
detailed molecular mechanism for this interaction.
The current studies implicate hbzmRNA rather thanHBZ protein in
promoting Tax expression and activity. Mutations that disrupt the
coding capacity of hbz but do not affect hbzmRNA, pACH.HBZ-KO and
pACH.HBZ-TRUN, did not perturb Tax expression (Figs. 2 and 3). It has
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is important for its growth-promoting activity (Satou et al., 2006). It is
conceivable that this stem–loop RNA sequence may bind speciﬁc
cellular proteins or is processed into microRNA that could inhibit
other viral genes. However, in the current studies, pACH.HBZ-SL
exhibited similar activity to pACH.HBZ-WT with respect to Tax
expression (Fig. 3). This suggests that the effects of hbz mRNA in
promoting Tax expression are not speciﬁcally localized to the 5’ stem–
loop structure.
An interesting recent observation is that the spliced hbz transcript
(hbz SP1) and the pX region are present in all ATLL cell lines,
regardless of levels of tax expression (Matsuoka and Green, 2009;
Satou et al., 2006). Since it is known that Tax elicits a strong cytotoxic
T-lymphocyte (CTL) response in vivo, it is conceivable that the virus
has evolved intricate mechanisms to regulate the levels of Tax, in
order to maximize its spread. It is possible that hbz and p30II work
together to provide this tight regulation early in infection. A possible
model of how the hbz mRNA controls tax expression, via p30II, is
shown in Fig. 6. This model proposes that hbz mRNA down-regulates
p30II mRNA and inhibits synthesis of the p30II protein (Fig. 6, step 1).
Thus, in the presence of hbzmRNA, less p30II protein is present in the
nucleus (step 2) to retard tax mRNA nucleo-cytoplasmic transport
(step 3). Consequentially, taxmRNA is more readily transported to the
cytoplasm, and translated (step 4). Therefore, in the presence of hbz
mRNA, there is an increased level of Tax protein and thus, increased
levels of other viral gene products. These hypotheses, testable in
animal models and clinical studies, may provide new insights into
HTLV-1 pathogenesis.Materials and methods
Cells
293T cells were maintained in Dulbecco's Modiﬁed Eagle Medium
(DMEM), supplemented with 10% FetalClone III (FCIII) serum
(Hyclone), 2 mM glutamine, 1 mM sodium pyruvate, penicillin (100
U/mL), and streptomycin (100 μg/mL).Fig. 6.Model for effect of hbz on tax. Schematic representation of a possible mechanism
for hbz's control of tax: (1) hbz mRNA inhibits p30II mRNA, which (2) leads to a
reduction in the amount of p30II protein. Thus, less p30II is translocated to the nucleus,
and as a result, (3) less tax mRNA is retained in the nucleus. (4) This results in the
synthesis of more Tax protein, leading to an increase in viral gene expression and virus
production.Plasmids
The HTLV-1 molecular proviral clone pACH was used in this study
(Kimata et al., 1994). Site directed mutagenesis was performed by a
PCR overlap extension method (Higuchi et al., 1988). pACH.HBZ-ΔSA
was generated by introducing a T to G silent point mutation (nt.
7268), which abolishes the splice acceptor site of the hbz gene. pACH.
HBZ-KO was generated by introducing a G to A point mutation (nt.
7258), which terminates the HBZ protein at amino acid seven (HBZ
SP1 open reading frame). This mutation also results in an arginine to
glutamine change in the p30II accessory protein. However, this does
not affect the activity of p30II (Arnold et al., 2006). pACH.HBZ-TRUN
was generated by introducing a C to A point mutation (nt. 6807),
which terminates the HBZ protein at amino acid 158, and truncates
the protein by deleting its leucine zipper domain. pACH.HBZ-SL was
generated by mutating the sequence 8670GGC8672 to TTT. This change
was based on a previously described mutant, which mutates the
stem–loop structure in the hbz gene (Satou et al., 2006). pACHΔp30
and pACH.HBZ-ΔSAΔp30 were generated by introducing a C to G
point mutation (nt. 6850) in pACH and pACH.HBZ-ΔSA, respectively.
This mutation terminates the p30II protein at amino acid eight. The
sequence numbers are based on that of pACH. To ensure that the
mutations had no effect on the integrity of the proviral plasmids, we
digested the plasmids with the PvuII restriction enzyme, to check for
any gross deletions in the plasmids, and sequence analysis of the
plasmids was performed. The HBZ expression vectors, pHBZ1 and
pHBZ2, were generated by cloning the hbz SP1 cDNA into the SnaBI
and XbaI and EcoRI and XbaI sites of p3xFLAG-CMV™-14 (Sigma-
Aldrich), respectively. The mutant HBZ expression plasmids, pHBZ-
KO, pHBZ-TRUN, and pHBZ-SL, were generated in a similar manner to
pHBZ1, by cloning the mutant hbz SP1 cDNAs. The modiﬁed HBZ
expression vector, pNHBZ, was generated by cloning the hbz SP1 cDNA
into the EcoRI and BamHI sites of p3xFLAG-CMV™-10 (Sigma-
Aldrich). The pNHBZ-ΔSA plasmid was generated by amplifying the
sequence corresponding to the two hbz SP1 exons and the intronic
region from pACH.HBZ-ΔSA, and cloning into the same plasmid as
pNHBZ. The pmHBZ plasmid was generated by mutating the initiating
ATG in pHBZ2 to TTG. The pMHp30IIHA1 plasmid was a generous gift
from Dr. C. Nicot (Nicot et al., 2004). The LTR-luciferase (LTR-luc)
reporter plasmid and the CMV-Tax plasmid have been described
previously (Rauch et al., 2009; Smith and Greene, 1990).
Transfections and luciferase assay
To test the various mutants, 5×106 293T cells were transfected
with 10ug of pACH, a mutant proviral plasmid, or an empty plasmid,
in the presence or absence of 5ug of pHBZ1. At 96 h post-transfection,
the cells were washed from the plate and pelleted. The supernatants
were ﬁltered through 0.45 μm ﬁlters (Corning) and subjected to
ultracentrifugation in a Beckman-Coulter L7 Ultracentrifuge. These
lysates were used for Western blot analysis. The cell pellets were
washed with PBS; half of the cells were used for real-time RT-PCR,
while the other half was used forWestern blot analysis. 293T (3×106)
cells were transfected with 5ug of pHBZ1 or pNHBZ, a mutant HBZ
expression plasmid, or an empty plasmid. At 48 h post-transfection,
the cells pellets were lysed and used for Western blot analysis. 293T
(3×106) cells were transfected with 3ug of pMHp30IIHA1, and either
0.5ug, 2ug, or 8ug of pHBZ2 or pmHBZ, or 5ug of pHBZ2, pmHBZ,
pNHBZ, or pNHBZ-ΔSA. DNA levels were kept constant with empty
vector. At 48 h post-transfection the cell pellets were lysed, and used
for real-time RT-PCR, or Western blot analysis. To test for Tax activity,
2.5×105 293T cells were transfected with 1 ng LTR-luc, 1ug of pACH/
mutant, pCMV-Tax, and 0, 2, 3, or 4ug of pHBZ. Empty vector was
included to equalize the amount of DNA added, where necessary. At
48 h post-transfection, the cell pellets were resuspended in lysis
buffer and subjected to a luciferase assay (Luciferase Assay System,
314 G. Choudhary, L. Ratner / Virology 410 (2011) 307–315Promega). All transfections were carried out using TransIT-LT1
Transfection Reagent (Mirus) according to the manufacturer's
recommendations. Five million Jurkat cells were transfected with
15ug of pACH.HBZ-WT or pACH.HBZ-ΔSA proviral plasmids, using
polyethylenimine (PEI) transfection reagent (Sigma-Aldrich).
Quantitative real-time RT-PCR
Total RNAwas extracted from transfected 293T cells using the RNeasy
kit (Qiagen).OnemicrogramofRNAwas subjected to reverse transcription
using the SuperScript™ III First-Strand Synthesis System (Invitrogen).
Gene-speciﬁc reverse primers were used to generate cDNAs; the primers
used were as follows: tax(GCtaxR)-7649CCATTTCGGAAGGGGGAG-
TATTTGC
7625
, hbz SP1 and total hbz (GChbzoR)-6857TTGTCTCCACTTGCGCT-
CACGGCG
6880
, and p30 (GChbzoF)-ATGGTTAACTTTGTATCTGTAGGGC.
Reactions were performed both in the presence and absence of reverse
transcriptase to control for DNA contamination. The cDNAs (3μL) were
subjected to real-time PCR using a 2× iQ SYBR Green Supermix
(Bio-Rad) and gene-speciﬁc primer pairs (500nM each), as follows:
Tax (GCtaxF)-5117AGCTGCATGCCCAAGACCCGTCGGA5141 and GCtaxR,
HBZ SP1 (GChbznF)-8799TCTAAGGGAGCGCCGGACAAAG8778 and
GChbzoR, total HBZ (GChbztotalF)-AAACGCATCGTGATCGGCAGC and
GChbzoR, and p30-GChbzoR and GChbzoF. The amount of each
transcript present was determined based on a speciﬁc standard curve
generated from log10 dilutions of plasmids containing cloned copies of
the particular ampliﬁed sequences. Samples and standards were run in
triplicate and the ﬁnal values were averaged, after background values
were subtracted.
Western blot analysis
Cell lysates were prepared using lysis buffer (50 mMTris–Cl, pH 6.8,
150 mM NaCl, 1 mM EDTA, 1% Triton X-100) plus protease inhibitors.
Lysate (200 μg) was separated by 12% sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE), transferred to poly-
vinylidene ﬂuoride (PVDF; Millipore) membranes, blocked with 5% dry
milk in TBS-Tween (10 mMTris–Cl, pH7.5, 150 mMNaCl, 0.05% Tween-
20) and probed overnight with 1:100 HTLV-1 positive patient serum
(p19, p24), 1:25 anti-Tax antibody (supernatant from hybridoma cell
line 168A51-42; NIH AIDS Research & Reference Reagent Program)
(Langton et al., 1988), 1:1000 anti-Flag antibody (Sigma-Aldrich), 1:500
anti-HBZ antiserum (a generous gift from Dr. P. L. Green), or 50 mU/mL
horseradish peroxidase (HRP)-conjugated anti-HA antibody (3F10,
Roche) or for 30 minutes with an HRP-conjugated anti-actin antibody
(1:2000; Santa Cruz Biotechnology, Inc.). After washing with TBS-
Tween, the appropriate HRP-labeled secondary antibody was added
(1:3000 anti-human antibody [Amersham], 1:5000 anti-mouse anti-
body [Amersham], or 1:2000 anti-rabbit antibody [Pierce]). The blots
were developed using SuperSignal West Femto substrate (Pierce) and
the proteins were visualized with an Alpha Innotech imager (Model:
ChemiImager).
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